Nutra Pharma Corp (NPHC) Other Non-Current Assets (2010 - 2025)

Nutra Pharma has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $8803.0 for Q3 2025.

• In Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $8803.0; the TTM figure through Sep 2025 stood at $8803.0 (changed 0.0% YoY), while the FY2024 annual figure was $8803.0, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $8803.0 for Q3 2025 at Nutra Pharma, roughly flat from $8803.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8803.0 in Q1 2021 to a low of $8803.0 in Q1 2021.
• Average Other Non-Current Assets over 5 years is $8803.0, with a median of $8803.0 recorded in 2021.
• The largest YoY upside for Other Non-Current Assets was 0.0% in 2021 against a maximum downside of 43.39% in 2021.
• Over 5 years, Other Non-Current Assets stood at $8803.0 in 2021, then changed by 0.0% to $8803.0 in 2022, then changed by 0.0% to $8803.0 in 2023, then changed by 0.0% to $8803.0 in 2024, then changed by 0.0% to $8803.0 in 2025.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $8803.0 in Q3 2025, $8803.0 in Q2 2025, and $8803.0 in Q1 2025.